This HTML5 document contains 123 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1517/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33419597
rdf:type
wikibase:Item
schema:description
2015年の論文 2015年论文 article scientifique (publié 2015) artigo científico (publicado na 2015) 2015年論文 научни чланак 2015年論文 articolo scientifico bài báo khoa học naučni članak tieteellinen artikkeli 2015年论文 2015年论文 სამეცნიერო სტატია مقالة علمية wetenschappelijk artikel مقالهٔ علمی мақолаи илмӣ vedecký článok artículu científicu espublizáu en 2015 επιστημονικό άρθρο 2015年论文 vědecký článek 2015 թվականի հունվարին հրատարակված գիտական հոդված vitskapeleg artikkel artigo científico bilimsel makale vetenskaplig artikel tudományos cikk научна статия מאמר מדעי 2015 nî lūn-bûn 2015年論文 ২০১৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ سائنسی مضمون artikull shkencor 2015 թուականի Յունուարին հրատարակուած գիտական յօդուած wissenschaftlicher Artikel mokslinis straipsnis artykuł naukowy artículo científico publicado en 2015 2015年论文 articol științific artigo científico (publicado na 2015) научни чланак scientific article 2015年論文 2015년 논문 article científic vitenskapelig artikkel scienca artikolo teaduslik artikkel article scientific videnskabelig artikel (udgivet 2015) научная статья บทความทางวิทยาศาสตร์ мақолаи илмӣ 2015年论文 2015年論文 наукова стаття, опублікована в січні 2015 artikulong pang-agham
p:P577
wds:Q33419597-4E076A78-8662-4438-87B3-AD21522BFEC5
wdt:P577
2015-01-05T00:00:00Z
p:P407
wds:Q33419597-AF07A9F0-EF4B-4AC7-8AA9-2564117CB7BA
wdt:P407
wd:Q1860
p:P2860
wds:Q33419597-67AD305A-EC84-456F-ACC6-8FC107A35060 wds:Q33419597-7CC8DBE1-7829-4F05-BF1E-C1536AB6A361 wds:Q33419597-9043F5C6-75E3-4610-B3E0-E3A5D4DAA885 wds:Q33419597-CD4B9D85-4746-426B-B79E-1809EBDE1BFE wds:Q33419597-E3F13597-82E5-46C8-BE7C-D1C5FC749CC1 wds:Q33419597-01A12EBD-E43E-48B8-8C92-B827D830BDC5 wds:Q33419597-1BD1C58F-CA40-4D51-9F8D-A9DF1381F0B8 wds:Q33419597-3416EEE5-7517-4E93-9272-A49E6D28CDE2 wds:Q33419597-42F3A3EF-2D4F-433D-BE00-936659CB1838
wdt:P2860
wd:Q45950536 wd:Q33372371 wd:Q37415003 wd:Q33384848 wd:Q46463477 wd:Q53137731 wd:Q37768112 wd:Q33397646 wd:Q38004025
p:P2093
wds:Q33419597-AC4CC467-8EC8-4497-9456-59D32A32A027 wds:Q33419597-9D38D8D2-A581-4BC1-B0F9-0B199417CCB5 wds:Q33419597-A81A6459-AB17-410F-848E-6EAB40599568 wds:Q33419597-42DAEE79-6D82-406E-A567-ED27107E2AA6 wds:Q33419597-E2F6B0BB-5FEB-49E3-B4C1-FCEA916079F2 wds:Q33419597-B7214B9C-2AF8-4ABD-AFD5-00A7EA2B7EB0
wdt:P2093
Thomas Felix Machaon Bonafede J Michael Sprafka Michael Malecki Edward Li Gustavo Grampp
rdfs:label
Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars
skos:prefLabel
Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars
schema:name
Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars
p:P1476
wds:Q33419597-4D048177-517B-47C3-BACC-1F46387DEFBB
wdt:P1476
Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars
p:P304
wds:Q33419597-5DBF643C-64B4-4369-84F5-94FFF0FA87A2
wdt:P304
349-360
p:P31
wds:Q33419597-5CBAC991-A815-4D25-8271-63670A7DC975
wdt:P31
wd:Q13442814
p:P698
wds:Q33419597-F95E5C2C-22D0-4DB9-8B88-4E1C9319F24B
wdtn:P698
n12:25557261
wdt:P698
25557261
p:P1433
wds:Q33419597-6A682CB2-D63D-4843-A856-A0D76BE380C2
wdt:P1433
wd:Q5421206
p:P433
wds:Q33419597-BE654257-8C12-4982-A0C1-49AE5CAAD917
p:P478
wds:Q33419597-99206418-D5AD-4B2B-A6ED-0ADD0779A38D
wdt:P433
3
wdt:P478
14
p:P356
wds:Q33419597-7B84007D-EE6B-452E-88EB-DC2CF0BF686F
wdtn:P356
n11:14740338.2015.1001364
wdt:P356
10.1517/14740338.2015.1001364